FCF1P11: A Drug Target / Disease Biomarker (G100132310)
FCF1P11: A Drug Target / Disease Biomarker
FCF1P11 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.
FCF1P11 is a 11-kDa protein that is expressed in the brain, heart, and kidneys. It is localized to the dendrites of neurons and the intercellular junctions of epithelial cells. FCF1P11 is involved in a wide range of physiological processes, including neurotransmitter signaling, ion channels, and cell signaling.
One of the key functions of FCF1P11 is its role in neurotransmission. FCF1P11 is involved in the release of neurotransmitters, such as dopamine, norepinephrine, and serotonin. These neurotransmitters play a crucial role in brain function, including motivation, emotion, and memory.
In addition to its role in neurotransmission, FCF1P11 is also involved in cell signaling. It is a member of the GPCR family, which is involved in a wide range of cellular signaling processes. FCF1P11 is involved in the regulation of ion channels, which are responsible for the flow of electrical current through cells.
FCF1P11 is also involved in the regulation of cell adhesion. It is a member of the cadherin family, which is involved in cell-cell adhesion. FCF1P11 is involved in the regulation of cadherin interactions, which are important for the maintenance of tissue structure and the development of organs.
FCF1P11 is also involved in the regulation of inflammation. It is a member of the nuclear factor kappa B (NFKB) signaling pathway, which is involved in the regulation of inflammation and immune responses. FCF1P11 is involved in the regulation of NFKB signaling, which is important for the development of inflammatory diseases.
In conclusion, FCF1P11 is a protein that is involved in a wide range of physiological processes, including neurotransmission, cell signaling, and inflammation. As a drug target or biomarker, FCF1P11 may be useful in the development of new treatments for a wide range of diseases, including neurodegenerative diseases, psychiatric disorders, and inflammatory diseases.
Protein Name: FCF1 Pseudogene 11
More Common Targets
FCF1P2 | FCF1P5 | FCGBP | FCGR1A | FCGR1BP | FCGR1CP | FCGR2A | FCGR2B | FCGR2C | FCGR3A | FCGR3B | FCGRT | FCHO1 | FCHO2 | FCHSD1 | FCHSD2 | FCMR | FCN1 | FCN2 | FCN3 | FCRL1 | FCRL2 | FCRL3 | FCRL4 | FCRL5 | FCRL6 | FCRLA | FCRLB | FCSK | FDCSP | FDFT1 | FDPS | FDPSP2 | FDPSP4 | FDPSP5 | FDPSP6 | FDPSP7 | FDX1 | FDX2 | FDXACB1 | FDXR | FECH | FEM1A | FEM1AP4 | FEM1B | FEM1C | FEN1 | FENDRR | FER | FER1L4 | FER1L5 | FER1L6 | FER1L6-AS1 | FER1L6-AS2 | FERD3L | FERMT1 | FERMT2 | FERMT3 | Ferritin | FES | Fetal Hemoglobin (HbF) | FETUB | FEV | FEZ1 | FEZ2 | FEZF1 | FEZF1-AS1 | FEZF2 | FFAR1 | FFAR2 | FFAR3 | FFAR4 | FGA | FGB | FGD1 | FGD2 | FGD3 | FGD4 | FGD5 | FGD5-AS1 | FGD5P1 | FGD6 | FGF1 | FGF10 | FGF10-AS1 | FGF11 | FGF12 | FGF12-AS2 | FGF13 | FGF13-AS1 | FGF14 | FGF14-AS1 | FGF14-AS2 | FGF14-IT1 | FGF16 | FGF17 | FGF18 | FGF19 | FGF2 | FGF20